Status:
WITHDRAWN
CAPTION AI to Minimize Risk of COVID Exposure
Lead Sponsor:
Duke University
Collaborating Sponsors:
Caption Health, Inc.
Conditions:
COVID-19
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Participants scheduled for for an echocardiogram (echo) and being evaluated for, or is positive for COVID-19 will be asked if they would be willing to have their echo done using a new software program...
Detailed Description
To enable healthcare professionals that are not proficient in transthoracic echo (TTE) to acquire images in patients being evaluated for or positive for COVID-19. By leveraging the capabilities of the...
Eligibility Criteria
Inclusion
- Duke patients within the MICU and COVID overflow areas
- transthoracic echocardiogram ordered by their provider
- suspected or positive for COVID-19.
- Patients who consent to participating in the study or Physician discretion that information to be gained is important to the patient
- Patients ≥18 years old
Exclusion
- Unable to lie flat for study
- Patients unwilling to give consent
Key Trial Info
Start Date :
July 1 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
November 9 2020
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT04336774
Start Date
July 1 2020
End Date
November 9 2020
Last Update
August 10 2020
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Duke Health
Durham, North Carolina, United States, 27710
2
Duke University Medical Center
Durham, North Carolina, United States, 27710